Pigmented paravenous retinochoroidal atrophy

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:251295OMIM:172870H35.5
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Pigmented paravenous retinochoroidal atrophy (PPRCA), also known as pigmented paravenous chorioretinal atrophy, is a rare, typically non-progressive or slowly progressive retinal disorder characterized by distinctive pigment accumulation and chorioretinal atrophy distributed along the retinal veins in a radiating pattern from the optic disc toward the periphery. The condition primarily affects the eye, specifically the retina and choroid (the vascular layer beneath the retina). The hallmark finding on fundus examination is bone spicule-like pigment clumping adjacent to the retinal veins, accompanied by areas of retinal pigment epithelium (RPE) and choroidal atrophy in a paravenous distribution. Most patients with PPRCA are asymptomatic or have only mild visual complaints, as central vision is often preserved. Some individuals may experience mild visual field defects corresponding to the areas of atrophy, nyctalopia (night blindness), or reduced electroretinogram (ERG) responses. The condition is usually discovered incidentally during routine eye examinations. Visual acuity typically remains good unless the macula becomes involved in advanced cases. The exact etiology of PPRCA remains unclear. Most cases appear to be sporadic, though rare familial cases have been reported. Proposed causes include inflammatory, infectious, or degenerative mechanisms, but none have been definitively established. There is no specific treatment for PPRCA. Management involves regular ophthalmologic monitoring to track any progression and to detect potential complications. The prognosis is generally favorable, as the condition tends to remain stable or progress very slowly over many years.

Also known as:

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Pigmented paravenous retinochoroidal atrophy.

View clinical trials →

No actively recruiting trials found for Pigmented paravenous retinochoroidal atrophy at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Pigmented paravenous retinochoroidal atrophy community →

No specialists are currently listed for Pigmented paravenous retinochoroidal atrophy.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Pigmented paravenous retinochoroidal atrophy.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Pigmented paravenous retinochoroidal atrophyForum →

No community posts yet. Be the first to share your experience with Pigmented paravenous retinochoroidal atrophy.

Start the conversation →

Latest news about Pigmented paravenous retinochoroidal atrophy

No recent news articles for Pigmented paravenous retinochoroidal atrophy.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Pigmented paravenous retinochoroidal atrophy

What is Pigmented paravenous retinochoroidal atrophy?

Pigmented paravenous retinochoroidal atrophy (PPRCA), also known as pigmented paravenous chorioretinal atrophy, is a rare, typically non-progressive or slowly progressive retinal disorder characterized by distinctive pigment accumulation and chorioretinal atrophy distributed along the retinal veins in a radiating pattern from the optic disc toward the periphery. The condition primarily affects the eye, specifically the retina and choroid (the vascular layer beneath the retina). The hallmark finding on fundus examination is bone spicule-like pigment clumping adjacent to the retinal veins, accom

How is Pigmented paravenous retinochoroidal atrophy inherited?

Pigmented paravenous retinochoroidal atrophy follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.